Ignite Creation Date:
2025-12-24 @ 11:44 PM
Ignite Modification Date:
2025-12-26 @ 4:49 PM
Study NCT ID:
NCT00015951
Status:
COMPLETED
Last Update Posted:
2019-10-17
First Post:
2001-05-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bevacizumab, Cytarabine, and Mitoxantrone on Treating Patients With Hematologic Cancers
Sponsor:
University of Maryland, Baltimore
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-04
Start Date Type:
None
Primary Completion Date:
2003-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2004-03
Completion Date Type:
ACTUAL
First Submit Date:
2001-05-06
First Submit QC Date:
None
Study First Post Date:
2003-01-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-10-15
Last Update Post Date:
2019-10-17
Last Update Post Date Type:
ACTUAL